DexCom Financials

DexCom Stock Summary

DexCom competes with Superior Plus, Origin Agritech, Identiv, and INTUITIVE SURGICAL. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.

DexCom Key Financial Ratios

There are many critical financial ratios that DexCom's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that DexCom Inc reports annually and quarterly.

DexCom Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining DexCom's current stock value. Our valuation model uses many indicators to compare DexCom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DexCom competition to find correlations between indicators driving DexCom's intrinsic value. More Info.DexCom Inc is rated # 5 in return on equity category among its peers. It also is rated # 5 in return on asset category among its peers reporting about  0.29  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DexCom Inc is roughly  3.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DexCom's earnings, one of the primary drivers of an investment's value.

DexCom Inc Systematic Risk

Along with financial statement analysis, the daily predictive indicators of DexCom help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DexCom Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of DexCom Inc based on widely used predictive technical indicators. In general, we focus on analyzing DexCom Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DexCom's daily price indicators and compare them against related drivers.

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.